Cocaine, Marijuana, Designer Drugs : Chemistry, Pharmacology, and Behavior book cover
1st Edition

Cocaine, Marijuana, Designer Drugs
Chemistry, Pharmacology, and Behavior

ISBN 9780367204280
Published September 30, 2020 by CRC Press
238 Pages

SAVE ~ $13.00
was $65.00
USD $52.00

Prices & shipping based on shipping country


Book Description

Published in 1989: A comprehensive review of the chemical, clinical, pharmaco-logical, medical and social aspects of the chemicals that are widely abused is presented in this highly informative publication. The contributing authors represent expertise in clinical medicine, pharmacy, chemistry, pharmacology, social work and psychiatry. The scientific discussion, phar-macokinetic, pharmacological, and analytical, is well tied to the behavioral aspects of substances of abuse, making this a unique publication.

Table of Contents

    1. Introduction

    Kinfe. K. Redda and Charles A. Walker

    2. The national Perspective of Drug Abuse

    Elaine M. Johnson

    3. Behavorial Pharmacology of Drug Abuse

    James P. Cleary and Kenneth D. McIntire

    4. Getting Involved in Drug Abuse Education and Prevention

    Carol Bolach

    5. Pharmacology of Cocaine Abuse

    Roger M. Brown

    6. Cocaine Kinetics in Humans

    John J. Ambre

    7. Cocaine Pharmacology and Toxicology

    Randall L. Commissaris

    8. Cocaine Use in Man: Subjective Effects, Physiologic Responses, and Toxicity

    Karen M. Kumor, Michael A. Sherrer, and Nicola G. Cascella

    9. Treatment of Cocaine Abuse: Medical and Psychiatric Consequences

    Maria-Elena Rodriguez

    10. Marijuana Pharmacokinetics and Pharmacodynamics

    C. Nora Chiang and Gene Barnett

    11. Marijuana Abuse: Its Pharmacology and Effects on Testicular Function

    Syed Husain

    12. Marijuana Analysis and Detection of Use Through Urinalysis

    Mahmoud A. Elsohly and Hala N. Elsohly

    13. Designer Drugs: An Overview

    Gene Barnett and Rao S. Rapaka

    14. Substituted Amphetamine Controlled Substance Analogues

    David E. Nichols

    15. Pharmacology and Toxicology of MPTP: A Neurotic By-Product of Illicit Designer Drug Chemistry

    Anthony Trevor, Neal Castagnoli, Jr., and Thomas P. Singer

    16. Methyl-Phenyl-Tetrahydropyridine Neurotoxicity: From Clandestine Drug Synthesis to a Model for Parkinson’s Disease

    Jordi Cami

    17. Uses and Abuses of Anabolic Steroids by Athletes

    Sayed M. H. Al-Habet, Kinfe K. Redda, and Henry J. Lee

    View More



    Kinfe "Ken" Redda, Ph.D., is at present an Associate Professor of Medicinal Chemistry at the College of Pharmacy and Pharmaceutical Sciences, Florida A & M University (FAMU), Tallahassee.

    Charles A. Walker, Ph.D., is presently Chancellor of the University of Arkansas at Pine Bluff.

    Gene Barnett, Ph.D., is presently serving as an associate of the Director of the Food and Drug Administration’s (FDA) Division of Cardio-Renal Drug Products in the area of drug pharmacokinetics.